$40.43
$0.09
(0.22%)
Quote as of 4:00 PM EST on 02/10/12
Cubist Pharmaceuticals, Inc.
NASDAQ:CBST
|
$40.43
$0.09
(0.22%)
|
|
| Today's Open | $40.01 |
|---|---|
| Previous Close | $40.34 |
| Daily Range | $39.63 - $40.61 |
| 52-Week Range | $21.39 - $42.39 |
| Market Cap | $2.49B |
| P/E Ratio | 14.94 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 830,031 |
| Average Daily Volume | 929,601 |
| Current FY EPS | $1.75 |
CBST Information
| Description |
|---|
| A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Alnylam Pharmaceuticals Shares Dropped: What You Need to Know
US STOCK FUTURES: HOT STOCKS TO WATCH
US STOCK FUTURES: HOT STOCKS TO WATCH
Cubicin Drives Cubist Pharma - Analyst Blog
The Gory Details of Cubist Pharmaceuticals' Earnings Miss
Earnings Preview: Cubist Pharma - Analyst Blog
Optimer Buoyant on Difficid Sales - Analyst Blog
Cubist's Preliminary Sales Impress - Analyst Blog
Cubist Pharma 4Q Revenue Tops Views; Cubicin Sales Up 25%
Trius Therapeutics Predicted to Rise on Rival to Pfizer Antibiotic
